Expedition Therapeutics Raises Oversubscribed $115 Million Series B Financing and Advances EXPD-101 into Phase 2 Clinical Trial for COPD Expedition Therapeutics, a clinical-stage biotechnology company focused on developing innovative oral small-molecule therapies for inflammatory and respiratory diseases, has announced two…
Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher to Accelerate Plozasiran Approval for Severe Hypertriglyceridemia Arrowhead Pharmaceuticals, Inc. has announced that it has entered into an agreement with an undisclosed third party to acquire a U.S. Food and Drug Administration (FDA)…
Family Heart Foundation Founder Katherine Wilemon Receives ASPC 2026 Honorary Fellow Award for Advancing Cardiovascular Disease Prevention The Family Heart Foundation, a leading nonprofit organization dedicated to research, education, advocacy, and patient support for inherited cardiovascular diseases, has announced that…
CareDx Reports Strong Second Quarter 2026 Results with 52% Revenue Growth and Raises Full-Year Financial Outlook CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine diagnostics company focused on transplant medicine, specialty oncology, and cell therapy, has announced strong financial results…
Pfizer and BioNTech Receive European Commission Approval for 2026–2027 XFG-Adapted COVID-19 Vaccine Across Europe Pfizer Inc. and BioNTech SE have announced that the European Commission (EC) has granted marketing authorization for their updated 2026–2027 COVID-19 vaccine, specifically designed to target…
Mainstay Medical Achieves Coverage Milestone with Highmark Mainstay Medical Holdings plc has announced a significant reimbursement milestone for its ReActiv8 Restorative Neurostimulation™ therapy, following a favorable coverage decision from Highmark Inc. The new medical policy, which became effective on July…
Feinstein Institutes Reveals the World’s First Comprehensive Vagus Nerve Map Northwell Health’s Feinstein Institutes for Medical Research has announced the release of the world’s first comprehensive anatomical map of the human vagus nerve, marking a major scientific milestone that is…
Zoetis Launches Portela® in Canada and Europe, Introducing the First Long-Acting Anti-NGF Therapy for Feline Osteoarthritis Pain Zoetis Inc. has announced the commercial launch of Portela® (relfovetmab) across Canada and the member states of the European Union, marking an important…
Teleflex Awarded National Group Purchasing Agreement with Premier to Expand Access to Advanced Vascular Access Solutions Teleflex Incorporated, a global provider of medical technologies designed to improve patient care and clinical outcomes, has announced that it has been awarded a…
LAPIX Therapeutics Completes Enrollment in Rheumatoid Arthritis Cohort of LPX-TI641 Clinical Trial, Advancing Development of First-in-Class Oral TIM 3/4 Agonist LAPIX Therapeutics, a clinical-stage biotechnology company focused on developing innovative immunomodulatory therapies for inflammatory and immune-mediated diseases, has announced the…
LianMedical Completes Merger with LianBio and Launches New Chapter as Medical Device Innovation Company LianMedical, formerly known as LianBio, has announced the successful completion of its previously disclosed corporate merger, marking a significant milestone in the company’s strategic transformation from…
Veradermics Reports Positive Phase 2 Results for Oral VDPHL01 in Female Pattern Hair Loss, Supporting Ongoing Pivotal Development Veradermics, Incorporated, a late-stage biopharmaceutical company focused on developing innovative therapies for pattern hair loss, has announced positive topline results from its…